EBITDA Margin: 14.64%
Is the EBITDA margin high or low?
The EBITDA margin of 14.64% is in line with its 5-year average of 13.72%, around the middle of its 5-year range (11.35%–17.92%).
As of Saturday, June 27, 2026. 2.12% below its 12-month average of 14.96%.
UHS EBITDA Margin
Reported quarterly EBITDA margin; no daily interpolation.
UHS Average EBITDA Margin Chart
UHS Current vs Average EBITDA Margin Chart
UHS EBITDA Margin Metrics
EBITDA MARGIN
14.64%
EBITDA MARGIN AVG TTM
14.96%
EBITDA MARGIN AVG 3Y
13.91%
EBITDA MARGIN AVG 5Y
13.72%
EBITDA MARGIN AVG 10Y
14.85%
EBITDA MARGIN AVG 15Y
15.78%
EBITDA MARGIN AVG 20Y
14.97%
CURRENT VS TTM AVG
-2.12%
CURRENT VS 3Y AVG
+5.26%
CURRENT VS 5Y AVG
+6.73%
CURRENT VS 10Y AVG
-1.41%
CURRENT VS 15Y AVG
-7.22%
CURRENT VS 20Y AVG
-2.15%
UHS Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Universal Health Services, Inc. (UHS) | $9.12B | 14.64% | 14.96% | 13.91% | 13.72% |
| Henry Schein, Inc. (HSIC)vs › | $9.68B | 8.11% | 8.11% | 8.28% | 8.19% |
| Tempus AI, Inc. (TEM)vs › | $9.80B | -18.44% | -56.37% | -54.16% | -65.42% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 18.42% | 17.41% | 19.12% | 20.05% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -7.87% | -5.60% | -1.35% | 0.44% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.39B | 22.69% | 18.62% | 20.95% | 21.80% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | -3.14% | -1.08% | -5.02% | -19.32% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 6.82% | 6.08% | -0.44% | -8.67% |
| Insulet Corp. (PODD)vs › | $10.96B | 21.67% | 20.24% | 16.36% | 15.66% |
| Bio-Techne Corporation (TECH)vs › | $11.12B | 17.40% | 22.43% | 29.14% | 30.66% |
Margin Comparison
Gross Margin
90.5%
EBITDA Margin
14.6%
Operating Margin
11.5%
Net Margin
8.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EBITDA Margin FAQ
- What is the EBITDA margin for Universal Health Services, Inc. (UHS)?
- The EBITDA margin for UHS stock is 14.64%.
- Is Universal Health Services, Inc.'s EBITDA margin high or low?
- The EBITDA margin of 14.64% is in line with its 5-year average of 13.72%, around the middle of its 5-year range (11.35%–17.92%).
- What is the TTM average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The TTM average EBITDA margin for UHS stock is 14.96%.
- What is the 3Y average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The 3Y average EBITDA margin for UHS stock is 13.91%.
- What is the 5Y average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The 5Y average EBITDA margin for UHS stock is 13.72%.
- What is the 10Y average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The 10Y average EBITDA margin for UHS stock is 14.85%.
- What is the 15Y average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The 15Y average EBITDA margin for UHS stock is 15.78%.
- What is the 20Y average EBITDA margin for Universal Health Services, Inc. (UHS)?
- The 20Y average EBITDA margin for UHS stock is 14.97%.
UHS EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 14.64% |
| 2025-12-31 | 15.17% |
| 2025-09-30 | 15.05% |
| 2025-06-30 | 15.23% |
| 2025-03-31 | 14.71% |
| 2024-12-31 | 15.05% |
| 2024-09-30 | 13.47% |
| 2024-06-30 | 14.94% |
| 2024-03-31 | 13.78% |
| 2023-12-31 | 12.87% |
| 2023-09-30 | 11.86% |
| 2023-06-30 | 11.95% |
| 2023-03-31 | 12.12% |
| 2022-12-31 | 11.89% |
| 2022-09-30 | 12.64% |
| 2022-06-30 | 11.35% |
| 2022-03-31 | 11.44% |
| 2021-12-31 | 13.65% |
| 2021-09-30 | 14.24% |
| 2021-06-30 | 17.92% |
| 2021-03-31 | 14.17% |
| 2020-12-31 | 17.75% |
| 2020-09-30 | 16.33% |
| 2020-06-30 | 17.74% |
| 2020-03-31 | 12.76% |
| 2019-12-31 | 16.18% |
| 2019-09-30 | 11.00% |
| 2019-06-30 | 16.35% |
| 2019-03-31 | 16.42% |
| 2018-12-31 | 13.72% |
| 2018-09-30 | 13.95% |
| 2018-06-30 | 16.19% |
| 2018-03-31 | 16.63% |
| 2017-12-31 | 17.12% |
| 2017-09-30 | 14.46% |
| 2017-06-30 | 16.97% |
| 2017-03-31 | 17.79% |
| 2016-12-31 | 17.03% |
| 2016-09-30 | 15.82% |
| 2016-06-30 | 17.88% |
| 2016-03-31 | 18.79% |
| 2015-12-31 | 18.34% |
| 2015-09-30 | 16.82% |
| 2015-06-30 | 19.02% |
| 2015-03-31 | 19.15% |
| 2014-12-31 | 19.95% |
| 2014-09-30 | 13.38% |
| 2014-06-30 | 19.02% |
| 2014-03-31 | 18.97% |
| 2013-12-31 | 18.40% |
| 2013-09-30 | 17.17% |
| 2013-06-30 | 21.03% |
| 2013-03-31 | 17.68% |
| 2012-12-31 | 20.15% |
| 2012-09-30 | 14.74% |
| 2012-06-30 | 17.64% |
| 2012-03-31 | 18.78% |
| 2011-12-31 | 15.48% |
| 2011-09-30 | 14.65% |
| 2011-06-30 | 16.07% |
| 2011-03-31 | 17.37% |
| 2010-12-31 | 12.29% |
| 2010-09-30 | 12.11% |
| 2010-06-30 | 13.73% |
| 2010-03-31 | 14.41% |
| 2009-12-31 | 13.18% |
| 2009-09-30 | 11.82% |
| 2009-06-30 | 16.43% |
| 2009-03-31 | 14.32% |
| 2008-12-31 | 11.26% |
| 2008-09-30 | 10.59% |
| 2008-06-30 | 12.75% |
| 2008-03-31 | 13.44% |
| 2007-12-31 | 11.43% |
| 2007-09-30 | 9.62% |
| 2007-06-30 | 13.01% |
| 2007-03-31 | 12.58% |
| 2006-12-31 | 10.81% |
| 2006-09-30 | 10.68% |
| 2006-06-30 | 12.99% |
| 2006-03-31 | 12.01% |
| 2005-12-31 | 10.57% |
| 2005-09-30 | 11.47% |
| 2005-06-30 | 11.47% |
| 2005-03-31 | 13.80% |
| 2004-12-31 | 13.32% |
| 2004-09-30 | 11.87% |
| 2004-06-30 | 12.32% |
| 2004-03-31 | 12.45% |
| 2003-12-31 | 13.03% |
| 2003-09-30 | 13.64% |
| 2003-06-30 | 15.12% |
| 2003-03-31 | 14.83% |
| 2002-12-31 | 13.75% |
| 2002-09-30 | 13.43% |
| 2002-06-30 | 14.15% |
Related Metrics
About Universal Health Services, Inc.
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Marc D. Miller